CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has been selected as a 2009 Technology Pioneer by the World Economic Forum. Each year, the World Economic Forum awards companies from a variety of fields who have demonstrated visionary leadership and are involved in the development of a life-changing technology.
